Insider · CIK 0001561736
Kenneth A Clark
director
Files at SMMT (Summit Therapeutics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +16,991 | $9.18 | $156k | 16,991 | Jan 6, 2025 |
| Oct 11, 2024 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +200,000 | - | - | 200,000 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.